U.S. | Business | Sports | Entertainment

Cleaner by Design: SaniSure Introduces PETG PharmaTainer™ Ultra-Clean Bottles & Carboys

Business Wire India

SaniSure® today announced the launch of PETG PharmaTainer™, a new line of bioprocessing bottles and carboys combining widely accepted, medical-grade Eastman Eastar® PETG 6763 resin (DMF#9987) with SaniSure’s proprietary process and advanced automation. This launch expands SaniSure’s established PharmaTainer® platform—extending its proven cleanliness, robustness, and performance attributes to include industry-standard PETG alongside its existing PET and PC offerings.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420641769/en/

 

 

PETG PharmaTainer™ bottles and carboys—RNase/DNase-free, ultra-clean, ready-to-use containers for bioprocessing applications.

PETG PharmaTainer™ bottles and carboys—RNase/DNase-free, ultra-clean, ready-to-use containers for bioprocessing applications.

 

Available in volumes from 10 mL stability vials to 10 L carboys — in sterile (gamma-irradiated) and non-irradiated configurations — PETG PharmaTainer supports the full bioprocessing workflow. Standard and fully custom assemblies with Cap2V8® closures and Cellgyn™ TPE tubing are available for both open and closed operations. Start with PharmaTainer in early-stage R&D and carry the same platform through clinical and commercial phases — eliminating the need for requalification when scaling.

 

For part numbers, ordering information, and technical specifications, visit sanisure.com/petg or contact your SaniSure representative.

 

 

“With PETG PharmaTainer™, we are shifting cleanliness from a post-processing step to a fully automated, built-in standard – enabling us to confidently deliver the cleanest bioprocessing containers on the market for our customers’ most critical applications. Our bottles provide the lowest possible levels of particulates, endotoxins and RNase/DNase – by design – while minimizing adoption timelines.”
— Steven Chevillotte, CEO of SaniSure®

 

 

Cleaner by Design: What Sets PETG PharmaTainer™ Apart

 

 

Our PETG PharmaTainer delivers a validated suite of cleanliness and compliance attributes consistent with those of our PET and PC bottles:

 

 

  • Ultra-Low Particle Levels: Certified to less than 5% of USP <788> limits for sub-visible particulates, tested at lot release — no post-wash required.
  • Exceptional Endotoxin Control: Results consistently below 0.001 EU/mL detection limit per USP <85> — achieved by design, not by washing.
  • RNase/DNase-Free Certified: Validated for nucleic acid-based therapies including mRNA, oligonucleotides, and gene therapy applications requiring contamination-critical containers.
  • Ready-to-Use — Sterile: Gamma-sterilized to SAL 10⁻⁶, minimizing the 2–3 days of washing, depyrogenation, and sterilization steps typically required with competitive products, reducing labor and contamination risk.
  • Freeze-Thaw Validated to −80°C: Suited for bulk drug substance cold chain, stability studies, and frozen intermediates across the full temperature range.
  • Drop-In PETG Replacement: One-to-one volume and format compatibility with legacy PETG bioprocessing bottles; a comparability guide and dedicated technical support are included to minimize change-control burden.

 

 

About SaniSure®

 

As a trusted Single-Use Technologies (SUT) expert, SaniSure brings deep expertise in complex flow paths and closed-system design – supporting the most demanding bioprocessing and advanced therapy workflows. In addition to the PETG PharmaTainer, SaniSure provides a wide array of high-quality components, custom assemblies and SUT solutions.

 

 

Where larger organizations often lack flexibility and smaller providers lack scale, SaniSure delivers the best of both – combining agility with end-to-end capabilities and deep vertical integration to help customers de-risk, scale, and innovate.

 

 

Learn more at sanisure.com

 

 

 

 

 

Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Publication takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More